| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $143.1M | — | +38.1% |
| Cost of Revenue | $32.6M | — | +62.2% |
| Gross Profit | $110.6M | — | +32.3% |
| R&D Expense | $39.3M | — | +29.2% |
| SG&A Expense | $22.3M | — | +42.8% |
| Operating Income | -$8.1M | — | -469.0% |
| Pre-tax Income | -$8.9M | — | -313.9% |
| Income Tax | -$11.7M | — | -5359.8% |
| Net Income | $2.8M | — | -36.5% |
| EPS (Basic) | $0.03 | — | -50.0% |
| EPS (Diluted) | $0.03 | — | -40.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $351.2M | -28.9% | +108.0% |
| Accounts Receivable | $95.0M | +17.7% | +82.6% |
| Inventory | $15.1M | +53.5% | +58.2% |
| Current Assets | $590.0M | -2.7% | +135.9% |
| Total Assets | $1.04B | +8.5% | +128.6% |
| Current Liabilities | $109.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.2M | — | +42.7% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$163.6M | — | -3663.3% |
| Financing Cash Flow | $3.4M | — | +56.3% |
| Free Cash Flow | $17.2M | — | +44.2% |
| +48.4% |
| Total Liabilities | $443.2M | +7.7% | +460.1% |
| Stockholders' Equity | $597.6M | +9.0% | +58.8% |